吲哚菁绿荧光成像辅助腹腔镜肝切除治疗结直肠癌肝转移的围术期与无复发生存结局:一项逆概率治疗加权分析
本研究为单中心回顾性队列,纳入340例接受肝切除的结直肠癌肝转移患者,比较腹腔镜联合吲哚菁绿荧光成像(L-ICG)、单纯腹腔镜(L-Non-ICG)与开腹三组。经IPTW校正后,L-ICG组手术时间更短、出血更少、R0切除率更高,切缘复发率显著低于L-Non-ICG组(15.3% vs 45.7%,p=0.001),但无复发生存与总生存三组无显著差异。
要点
- ICG荧光成像可提高腹腔镜肝切除的R0切除率并减少切缘复发。
- ICG组切缘复发率15.3%,显著低于非ICG腹腔镜组的45.7%。
- ICG未显著改善无复发生存与总生存。
核心结论
- ICG荧光成像改善结直肠癌肝转移腹腔镜肝切除的R0切除率与围术期结局,并降低切缘复发,但未显著影响总生存与无复发生存。
研究设计与样本
- 单中心回顾性队列研究,纳入340例接受肝切除的结直肠癌肝转移患者,分为L-ICG组、L-Non-ICG组和开腹组,采用多重插补与逆概率治疗加权(IPTW)减少偏倚。
主要发现
- L-ICG组较开腹组接受新辅助治疗比例更高、肿瘤更小。
- L-ICG组手术时间更短、出血更少、R0切除率高于其他两组。
- 复发见于70%患者,其中77%为肝内复发。
- L-ICG组切缘复发率显著低于L-Non-ICG组(15.3% vs 45.7%,p=0.001)。
- IPTW校正后,三组中位无复发生存与总生存无显著差异。
临床怎么用
- 在腹腔镜肝切除治疗结直肠癌肝转移时,可考虑使用ICG荧光成像辅助肿瘤定位与切缘评估,以提高R0切除并减少切缘复发。
局限性
- 本研究为单中心回顾性设计,尽管采用IPTW校正,仍可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colorectal cancer (CRC) frequently metastasizes to the liver, significantly worsening patient outcomes. While hepatectomy offers the best curative option for colorectal liver metastases (CRLM), margin recurrence remains a major challenge post-surgery. Intraoperative ultrasound (IOUS) aids tumor identification and margin determination, but its limitations in laparoscopic surgery necessitate additional methods. Indocyanine green fluorescence imaging (ICGFI) has emerged as a promising tool for tumor localization and margin assessment in CRLM. However, existing studies lack large cohorts and long-term outcomes. This study evaluates perioperative and long-term results of ICGFI-assisted laparoscopic hepatectomy in CRLM patients. METHOD: A retrospective cohort study was performed on CRLM patients who underwent liver resection at our single center. The study population was divided into three groups: the L-ICG group (laparoscopic hepatectomy with ICGFI), the L-Non-ICG group (laparoscopic hepatectomy without ICGFI), and the open group (open liver resection). Robust statistical methods including multiple imputations and inverse probability of treatment weighting (IPTW) were employed to minimize bias. RESULTS: A total of 340 CRLM patients who underwent hepatectomy were analyzed. The L-ICG group had a higher rate of neoadjuvant therapy and smaller tumor sizes compared to the open group. The L-ICG group also demonstrated shorter operative times, less blood loss, and a higher microscopically margin-negative (R0) resection rate than other two groups. Recurrence occurred in 70% of patients, with 77% being intrahepatic. Margin recurrence was significantly lower in the L-ICG group compared to the L-Non-ICG group (15.3% vs. 45.7%, p = 0.001). Median recurrence-free survival and overall survival did not differ significantly among groups after IPTW adjustment. CONCLUSION: ICGFI improves R0 resection rates, perioperative outcomes, and reduces margin recurrence in CRLM patients undergoing laparoscopic hepatectomy, though it does not significantly impact OS or RFS.
引用
- Wang G, Liu C, Qi W, et al. Perioperative and recurrence-free survival outcomes after laparoscopic hepatectomy for colorectal cancer liver metastases using indocyanine green fluorescence imaging: an inverse probability treatment weighted analysis. Surg Endosc. 2024. PMID: 39715956. doi:10.1007/s00464-024-11478-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。